Search research articles
Contact Us
Filters
Showing results (691-700 of 771) with videos related to
Page
of 78
Sort By:
Journal of the American Heart Association
|
May 23, 2024
Assessment of Days Alive Out of Hospital as a Possible End Point in Trials of Stroke Prevention for Atrial Fibrillation: A ROCKET AF Analysis
Josephine Harrington, Anne S Hellkamp, Kenneth W Mahaffey, et al.
Neurology
|
July 27, 2007
A multicenter trial of selegiline transdermal system for HIV-associated cognitive impairment
G Schifitto, J Zhang, S R Evans, et al.
Molecular & Cellular Proteomics : MCP
|
April 22, 2016
Quantitative Tagless Copurification: A Method to Validate and Identify Protein-Protein Interactions
Maxim Shatsky, Ming Dong, Haichuan Liu, et al.
Journal of the American Heart Association
|
March 26, 2013
Impact of global geographic region on time in therapeutic range on warfarin anticoagulant therapy: data from the ROCKET AF clinical trial
Daniel E Singer, Anne S Hellkamp, Jonathan P Piccini, et al.
Circulation. Cardiovascular Quality and Outcomes
|
June 14, 2013
Risks and benefits of anticoagulation in atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry
Michael W Cullen, Sunghee Kim, Jonathan P Piccini, et al.
American Heart Journal
|
March 25, 2014
Physician practices regarding contraindications to oral anticoagulation in atrial fibrillation: findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry
Emily C O'Brien, DaJuanicia N Holmes, Jack E Ansell, et al.
Thrombosis Research
|
April 24, 2017
Efficacy and safety of rivaroxaban versus warfarin in patients from mainland China with nonvalvular atrial fibrillation: A subgroup analysis from the ROCKET AF trial
Yihong Sun, Dayi Hu, Susanna Stevens, et al.
Clinical Cardiology
|
February 2, 2018
Efficacy and safety of rivaroxaban compared with warfarin in patients with carotid artery disease and nonvalvular atrial fibrillation: Insights from the ROCKET AF trial
Ajar Kochar, Anne S Hellkamp, Yuliya Lokhnygina, et al.
Circulation
|
June 5, 2014
Efficacy and safety of rivaroxaban compared with warfarin among elderly patients with nonvalvular atrial fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF)
Jonathan L Halperin, Graeme J Hankey, Daniel M Wojdyla, et al.
Heart (British Cardiac Society)
|
June 28, 2020
Patterns of oral anticoagulation use with cardioversion in clinical practice
Kyle Geurink, DaJuanicia Holmes, Michael D Ezekowitz, et al.
Page
of 78
Search research articles
Search
Showing results (691-700 of 771) with videos related to
Sort By:
Page
of 78
Journal of the American Heart Association
|
May 23, 2024
Assessment of Days Alive Out of Hospital as a Possible End Point in Trials of Stroke Prevention for Atrial Fibrillation: A ROCKET AF Analysis
Josephine Harrington, Anne S Hellkamp, Kenneth W Mahaffey, et al.
Neurology
|
July 27, 2007
A multicenter trial of selegiline transdermal system for HIV-associated cognitive impairment
G Schifitto, J Zhang, S R Evans, et al.
Molecular & Cellular Proteomics : MCP
|
April 22, 2016
Quantitative Tagless Copurification: A Method to Validate and Identify Protein-Protein Interactions
Maxim Shatsky, Ming Dong, Haichuan Liu, et al.
Journal of the American Heart Association
|
March 26, 2013
Impact of global geographic region on time in therapeutic range on warfarin anticoagulant therapy: data from the ROCKET AF clinical trial
Daniel E Singer, Anne S Hellkamp, Jonathan P Piccini, et al.
Circulation. Cardiovascular Quality and Outcomes
|
June 14, 2013
Risks and benefits of anticoagulation in atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry
Michael W Cullen, Sunghee Kim, Jonathan P Piccini, et al.
American Heart Journal
|
March 25, 2014
Physician practices regarding contraindications to oral anticoagulation in atrial fibrillation: findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry
Emily C O'Brien, DaJuanicia N Holmes, Jack E Ansell, et al.
Thrombosis Research
|
April 24, 2017
Efficacy and safety of rivaroxaban versus warfarin in patients from mainland China with nonvalvular atrial fibrillation: A subgroup analysis from the ROCKET AF trial
Yihong Sun, Dayi Hu, Susanna Stevens, et al.
Clinical Cardiology
|
February 2, 2018
Efficacy and safety of rivaroxaban compared with warfarin in patients with carotid artery disease and nonvalvular atrial fibrillation: Insights from the ROCKET AF trial
Ajar Kochar, Anne S Hellkamp, Yuliya Lokhnygina, et al.
Circulation
|
June 5, 2014
Efficacy and safety of rivaroxaban compared with warfarin among elderly patients with nonvalvular atrial fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF)
Jonathan L Halperin, Graeme J Hankey, Daniel M Wojdyla, et al.
Heart (British Cardiac Society)
|
June 28, 2020
Patterns of oral anticoagulation use with cardioversion in clinical practice
Kyle Geurink, DaJuanicia Holmes, Michael D Ezekowitz, et al.
Page
of 78